Search by Drug Name or NDC

    NDC 00169-2800-90 Saxenda 6 mg/mL Details

    Saxenda 6 mg/mL

    Saxenda is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is LIRAGLUTIDE.

    Product Information

    NDC 00169-2800
    Product ID 0169-2800_7bb9293e-2a23-4662-9174-01468567657d
    Associated GPIs 6125205000D220
    GCN Sequence Number 073258
    GCN Sequence Number Description liraglutide PEN INJCTR 3 MG/0.5ML SUBCUT
    HIC3 J8E
    HIC3 Description ANTI-OBESITY GLUCAGON-LIKE PEPTIDE-1 RECEP AGONIST
    GCN 37637
    HICL Sequence Number 036436
    HICL Sequence Number Description LIRAGLUTIDE
    Brand/Generic Brand
    Proprietary Name Saxenda
    Proprietary Name Suffix n/a
    Non-Proprietary Name liraglutide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 6
    Active Ingredient Units mg/mL
    Substance Name LIRAGLUTIDE
    Labeler Name Novo Nordisk
    Pharmaceutical Class GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA206321
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-2800-90 (00169280090)

    NDC Package Code 0169-2800-90
    Billing NDC 00169280090
    Package 1 SYRINGE, PLASTIC in 1 CARTON (0169-2800-90) / 3 mL in 1 SYRINGE, PLASTIC
    Marketing Start Date 2015-01-19
    NDC Exclude Flag N
    Pricing Information N/A